HomeMarket NewsINMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Actionable Trade Ideas

always free







INmune Bio Q4 2023: A Financial Stumble in the Dark

INmune Bio 2023 Q4 Earnings Report

INMB stock - INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

The Financial Misstep of INmune Bio

INmune Bio (NASDAQ:INMB) recently unveiled its financial performance for the final quarter of 2023:

  • Reported earnings per share stood at -47 cents, falling short of the projected -44 cents.
  • Revenue figures showed $28,000, a notable 30% dip compared to the anticipated $40,000.

InvestorPlace Earnings, powered by TradeSmith data, delivers automated updates on quarterly earnings. By swiftly sharing crucial insights like EPS and revenue, it offers a snapshot of a company’s performance against analyst forecasts. These reports are generated without human intervention to swiftly disseminate the latest financials. To flag any concerns or inaccuracies, reach out to us at [email protected].


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/inmb-stock-earnings-inmune-bio-for-q4-of-2023/.

Β©2024 InvestorPlace Media, LLC


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.